$AUXL Recent Headlines Auxilium shares soar afte
Post# of 102254
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - Russ Britt
Charting a slow-motion ‘break’ atop Nasdaq 4,000 12:34 p.m. Nov. 26, 2013 - Michael Ashbaugh
Charting a slow-motion ‘break’ atop Nasdaq 4,000 12:19 p.m. Nov. 26, 2013 - Michael Ashbaugh
Earnings, deals aid medical supplier, biopharmas on mixed market day 10:32 a.m. Oct. 11, 2013 - Russ Britt
Charting the S&P 500’s next technical target 10:47 a.m. July 19, 2013 - Michael Ashbaugh
Auxilium posts first quarterly profit; revenue up 9:20 a.m. July 31, 2012 - MarketWatch.com
U.S. benchmarks face technical hurdles 11:17 a.m. June 12, 2012 - Michael Ashbaugh
U.S. benchmarks face technical hurdles 10:49 a.m. June 12, 2012 - Michael Ashbaugh
S&P 500 balks at resistance 10:37 a.m. June 8, 2012 - Michael Ashbaugh
Monday’s biggest gaining and declining stocks 1:40 p.m. June 4, 2012 - MarketWatch
Auxilium shares rally on late-stage trial results 8:40 a.m. June 4, 2012 - MarketWatch.com
Nasdaq rises to the breakdown point 10:47 a.m. Dec. 16, 2011 - Michael Ashbaugh
Monday’s biggest gaining and declining stocks 4:17 p.m. Oct. 31, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 3:36 p.m. Aug. 1, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:40 p.m. Jan. 10, 2011 - Kate Gibson
Auxilium rallies; drug indexes dip 4:36 p.m. Jan. 10, 2011 - Val Brickates Kennedy
Auxilium rallies as drug indexes slide 10:04 a.m. Jan. 10, 2011 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:38 p.m. July 12, 2010 - MarketWatch
Market bulls defend the March peak 10:05 a.m. April 29, 2010 - Michael Ashbaugh
Wednesday's biggest gaining and declining stocks 4:19 p.m. Dec. 16, 2009 - MarketWatch
Jefferies hikes target on Auxilium citing PD potential 10:06 a.m. Today - Seeking Alpha
FDA Approves First Peyronie's Disease Drug Treatment 4:01 p.m. Dec. 6, 2013 - WSJ.com
Mid-Afternoon Market Update: Markets Gain on Jobs Number; InterOil Falls on Sale of Major Asset 3:00 p.m. Dec. 6, 2013 - benzinga.com
Auxilium Xiaflex Drug Wins New Label, Stock Jumps 1:27 p.m. Dec. 6, 2013 - Investors Business Daily
Auxilium Pharmaceuticals (AUXL) Marked As A Barbarian At The Gate 12:53 p.m. Dec. 6, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock Is Auxilium Pharmaceuticals (AUXL) 10:00 a.m. Dec. 5, 2013 - TheStreet.com
Summer Street out with bearish commentary on Auxilium 9:29 a.m. Dec. 5, 2013 - Seeking Alpha
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Auxilium: Serious Red Flags Make The Upcoming FDA Decision For Xiaflex A 'High Risk' 11:40 a.m. Dec. 2, 2013 - Seeking Alpha
Label Expansion for Roche's Avastin in Japan - Analyst Blog 11:40 a.m. Nov. 27, 2013 - Zacks.com
Novartis to Buy Back Shares - Analyst Blog 6:00 p.m. Nov. 25, 2013 - Zacks.com
4 Biotech Stocks With Upcoming FDA Decision Dates 9:14 a.m. Nov. 25, 2013 - Seeking Alpha
Auxilium Presented New Analyses of XIAFLEX Peyronie's Disease Data at SMSNA Meeting 6:01 a.m. Nov. 25, 2013 - benzinga.com
Data on Auxilium Pharma's Xiaflex - Analyst Blog 12:10 p.m. Nov. 22, 2013 - Zacks.com
Cadence Wins Lawsuit, Shares Up - Analyst Blog 6:02 p.m. Nov. 21, 2013 - Zacks.com
New Research And Competition Could Hurt AbbVie's Other Blockbuster 12:21 p.m. Nov. 21, 2013 - Seeking Alpha
First Week Of AUXL January 2014 Options Trading 11:55 a.m. Nov. 19, 2013 - TheStreet.com
Auxilium Announces Results Of The XIAFLEX In Dupuytren's MULTICORD Contracture Phase 3b Trial 6:05 a.m. Nov. 18, 2013 - benzinga.com
Auxilium Pharmaceuticals, Inc. (AUXL) Shares March Higher, Can it Continue? - Tale of the Tape 8:53 a.m. Nov. 14, 2013 - Zacks.com
Strategic Collaborations, Clinical Studies, Regulatory Update, and Other Corporate Announcements - Research Report on OncoMed, Auxilium Pharma, BioTelemetry, Progenics Pharma, and Ambit Biosciences 8:00 a.m. Today - PR Newswire
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX® for the Treatment of Peyronie's Disease 1:29 p.m. Dec. 6, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference 4:34 p.m. Dec. 5, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment 5:05 p.m. Dec. 4, 2013 - PR Newswire
Healthcare Sector Announces Acquisitions and Innovations - Research Report on Synta, Auxilium Pharmaceuticals, Accuray, and USANA 8:00 a.m. Nov. 29, 2013 - PR Newswire
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX® Peyronie's Disease Data at SMSNA Scientific Meeting 7:00 a.m. Nov. 25, 2013 - PR Newswire
Investments on New Facilities, Marketing Grants, Commercial Releases, and Trial Results - Research Report on AstraZeneca, Theravance, Accuray, Volcano, and Auxilium 8:00 a.m. Nov. 21, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. to Present Data on XIAFLEX® at the Fall Scientific Meeting of the Sexual Medicine Society of North America 7:00 a.m. Nov. 20, 2013 - PR Newswire
Auxilium Announces Results Of The XIAFLEX® In Dupuytren's MULTICORD Contracture Trial 7:00 a.m. Nov. 18, 2013 - PR Newswire
Healthcare Companies Report Financial Results, Scheduled Presentations, Marketing Clearance and Recognitions - Research Report on Air Methods, NeuroMetrix, Quintiles, Auxilium, and Cynosure 8:00 a.m. Nov. 12, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results 7:00 a.m. Nov. 6, 2013 - PR Newswire
Healthcare Sector Announced Financial Results - Research Report on Ligand, Auxilium, STERIS, USANA, and Cardiovascular Systems 8:00 a.m. Nov. 4, 2013 - PR Newswire
Arbitration Awards, Shareholder Meetings, Marketing Agreements, New Appointments and Upcoming Earnings Schedules - Research Report on Valeant, Perrigo, IDEXX, Auxilium, and PerkinElmer 9:00 a.m. Oct. 30, 2013 - PR Newswire
Auxilium Pharmaceuticals to Announce Third Quarter 2013 Results on November 6, 2013 9:00 a.m. Oct. 24, 2013 - PR Newswire
BioSpecifics Technologies Corp. Announces Initiation of Phase 2a Study of XIAFLEX for Treatment of Cellulite 9:35 a.m. Oct. 23, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum 8:00 a.m. Oct. 23, 2013 - PR Newswire
VIVUS, Inc. Announces License Agreement for the Marketing Rights to STENDRA in the United States and Canada 7:00 a.m. Oct. 11, 2013 - GlobeNewswire
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada 7:00 a.m. Oct. 11, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 8:00 a.m. Oct. 9, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX® For The Treatment Of Dupuytren's Contracture 7:30 a.m. Oct. 7, 2013 - PR Newswire